Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InMode Ltd. - Ordinary Shares (NQ:INMD)

14.66 -0.15 (-1.03%)
Streaming Delayed Price Updated: 10:31 AM EDT, Aug 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about InMode Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
InMode Ltd (NASDAQ:INMD) Embodies Peter Lynch's GARP Philosophy with Strong Growth and Undervalued Metrics
Discover InMode (INMD), a top GARP stock per Peter Lynch's strategy. Strong earnings growth, zero debt, and a low PEG ratio highlight its value in the medical aesthetics sector. 
Via Chartmill
INMODE LTD (NASDAQ:INMD): A Peter Lynch-Style GARP Investment with Strong Fundamentals and Undervalued Growth Potential
Peter Lynch’s GARP strategy highlights INMODE LTD (INMD) as a strong candidate with steady earnings, low debt, and undervalued growth potential. 
Via Chartmill
InMode Ltd (NASDAQ:INMD) Reports Mixed Q2 2025 Results: Revenue Miss but EPS Beat Drives Pre-Market Gains
InMode's Q2 2025 earnings show mixed results: revenue missed estimates at $95.6M, but EPS beat at $0.47. Shares rose 3.4% pre-market on strong profitability. 
Via Chartmill
Earnings Scheduled For July 30, 2025
 
Via Benzinga
What to Expect from InMode's Earnings
 
Via Benzinga
INMODE LTD (NASDAQ:INMD) – A Strong Candidate for GARP Investors
INMODE LTD (NASDAQ:INMD) offers strong growth, profitability, and an attractive valuation, making it a standout for GARP investors following Peter Lynch’s principles. 
Via Chartmill
Insights Ahead: InMode's Quarterly Earnings
 
Via Benzinga
NASDAQ:INMD is an undervalued gem with solid fundamentals.
Despite its impressive fundamentals, INMODE LTD (NASDAQ:INMD) remains undervalued. 
Via Chartmill
INMODE LTD (NASDAQ:INMD) – A Strong Candidate for GARP Investors
INMODE LTD (NASDAQ:INMD) offers strong growth, profitability, and value, making it a standout for GARP investors following Peter Lynch’s strategy. 
Via Chartmill
INMODE LTD (NASDAQ:INMD) – A Strong Candidate for GARP Investors
INMODE LTD (NASDAQ:INMD) offers strong growth, profitability, and value, making it a standout for GARP investors following Peter Lynch’s strategy. 
Via Chartmill
How does INMODE LTD (NASDAQ:INMD) stack up against Peter Lynch’s investment principles?
Lynch encouraged investors to look at businesses they understand and have strong financials. Does INMODE LTD (NASDAQ:INMD) align with this approach? We take a closer look. 
Via Chartmill
Applying Peter Lynch’s stock selection rules to INMODE LTD (NASDAQ:INMD)
Peter Lynch’s investment philosophy combines fundamental analysis with a deep understanding of business models. Let’s analyze if INMODE LTD (NASDAQ:INMD) meets his criteria for a solid investment. 
Via Chartmill
Why Peter Lynch may take an interest in INMODE LTD (NASDAQ:INMD)
With a strategy that emphasized steady earnings growth and a strong market position, Peter Lynch sought out long-term winners. We put INMODE LTD (NASDAQ:INMD) to the test against his stock-picking... 
Via Chartmill
Earnings Scheduled For April 28, 2025
 
Via Benzinga
InMode (INMD) Q4 2024 Earnings Call Transcript
INMD earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies. 
Via Benzinga
Earnings Scheduled For February 4, 2025
 
Via Benzinga
Under the Radar: From Overlooked to Overperforming - Global Markets Await
 
Via Benzinga
InMode (INMD) Q3 2024 Earnings Call Transcript
INMD earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
 
Via Benzinga
Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
InMode (INMD) Q2 2024 Earnings Call Transcript
INMD earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
3 MedTech Stocks to Buy for Healthy Gains
With innovations in healthcare moving at a rapid clip, investors should consider these enticing MedTech stocks to buy. 
Via InvestorPlace
InMode (INMD) Q1 2024 Earnings Call Transcript
INMD earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
INMD Stock Earnings: InMode Misses EPS, Misses Revenue for Q1 2024
INMD stock results show that InMode missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Nuvei's Going Private
We also check in on the latest Tesla news. 
Via The Motley Fool
Maxeon Solar Technologies, Neogen And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.2% on Tuesday. Shares of Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) fell sharply in today’s pre-market... 
Via Benzinga
Investors should take notice of NASDAQ:INMD—it offers a great deal for the fundamentals it presents.
INMODE LTD (NASDAQ:INMD) is probably undervalued for the fundamentals it is displaying. 
Via Chartmill
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.